Efficacy of 5-FU Combined with a Novel Antimetastatic Agent in Mice
Author Information
Author(s): M. Coluccia, G. Sava, G. Salerno, A. Bergamo, S. Pacor, G. Mestroni, E. Alessi
Primary Institution: Department of General Pathology and Oncology, University of Bari
Hypothesis
Does the combination of sodium-trans-rutheniumtetrachloridedimethylsulfoxide and 5-fluorouracil improve survival time in mice with leukemia and mammary carcinoma?
Conclusion
The combination treatment significantly prolongs survival time in mice with both MCa mammary carcinoma and P388 leukemia compared to single agents.
Supporting Evidence
- The combination of Na[trans-RuCl4(DMSO)lm] and 5-FU was more effective than either drug alone.
- Statistically significant prolongation of survival time was observed in treated mice.
- The study demonstrated that Na[trans-RuCl4(DMSO)lm] does not reduce the effectiveness of 5-FU.
Takeaway
Researchers found that using two cancer-fighting drugs together helps mice live longer than using just one.
Methodology
CBA female mice were treated with 5-FU and Na[trans-RuCl4(DMSO)lm] to assess effects on tumor growth and survival.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
CBA female mice, 5-6 weeks old, weighing approximately 22 grams.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website